Edition:
United Kingdom

HPGC Renmintongtai Pharmaceutical Corp (600829.SS)

600829.SS on Shanghai Stock Exchange

10.43CNY
7:59am BST
Change (% chg)

¥0.03 (+0.29%)
Prev Close
¥10.40
Open
¥10.38
Day's High
¥10.43
Day's Low
¥10.35
Volume
989,884
Avg. Vol
2,737,637
52-wk High
¥13.98
52-wk Low
¥10.12

Chart for

About

HPGC Renmintongtai Pharmaceutical Corporation, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., is a China-based company, principally engaged in the wholesale and retail of pharmaceuticals. The Company principally engages in the sales of Chinese medicines and western drugs. It also engages in the sales... (more)

Overall

Beta: 1.33
Market Cap(Mil.): ¥6,030.84
Shares Outstanding(Mil.): 579.89
Dividend: 0.50
Yield (%): 4.81

Financials

  600829.SS Industry Sector
P/E (TTM): 23.41 23.65 38.77
EPS (TTM): 0.44 -- --
ROI: 14.97 11.56 46.42
ROE: 16.59 13.33 54.22

BRIEF-HPGC Renmintongtai Pharmaceutical's Share Trade To Resume On Feb 27

* SAYS SHARE TRADE TO RESUME ON FEB 27 Source text in Chinese: http://bit.ly/2F73ehW Further company coverage: (Reporting by Hong Kong newsroom)

26 Feb 2018

BRIEF-Citic Capital To Become HPGC Renmintongtai Pharmaceutical's Owner After Stake Deals

* SAYS CITIC CAPITAL INVESTMENT FUND PLANS TO INVEST 1.5 BILLION YUAN ($228.87 million) IN CONTROLLING SHAREHOLDER HARBIN PHARMACEUTICAL GROUP

27 Dec 2017

BRIEF-HPGC Renmintongtai's board elects chairman

* SAYS BOARD ELECTS ZHANG ZHENPING AS CHAIRMAN Source text in Chinese: http://bit.ly/2AdOvPm Further company coverage: (Reporting by Hong Kong newsroom)

29 Nov 2017

Earnings vs. Estimates